Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –
Novartis Asia, Africa & Australasia (AAA) by Year
Novartis Asia, Africa & Australasia (AAA): 2,605 in FY2025, down 4.6% from a year earlier.
Latest, FY2025
2,605
Period ended Dec 31, 2025
Change on a year earlier
-4.6%
2,731 in FY2024
History
3 years
Since FY2023
Sources
1
Novartis Form 20-F (0001114448-26-000004)
Where the FY2025 figure comes from
“|| Asia/Africa/Australasia | 12 764 | 4 986 | 2 605 | 4 350 | 24 705”
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Reported in Form 20-F.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Asia, Africa & Australasia (AAA) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,605 | -4.6% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 2,731 | -0.1% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2023 | Dec 31, 2023 | 2,733 | – | Novartis Form 20-F (0001114448-26-000004) ↗ |
Cite this data
StockData. (2026). Novartis Asia, Africa & Australasia (AAA), annual FY2023–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/wf-fte-prod-aaa
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.